Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

An antibiofilm coating of 5-aryl-2-aminoimidazole covalently attached to a titanium surface.

Peeters E, Hooyberghs G, Robijns S, De Weerdt A, Kucharíková S, Tournu H, Braem A, Čeh K, Majdič G, Španič T, Pogorevc E, Claes B, Dovgan B, Girandon L, Impellizzeri F, Erdtmann M, Krona A, Vleugels J, Fröhlich M, Garcia-Forgas J, De Brucker K, Cammue BPA, Thevissen K, Van Dijck P, Vanderleyden J, Van der Eycken E, Steenackers HP.

J Biomed Mater Res B Appl Biomater. 2018 Dec 13. doi: 10.1002/jbm.b.34283. [Epub ahead of print]

PMID:
30549192
2.

Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.

Winderickx S, De Brucker K, Bird MJ, Windmolders P, Meert E, Cammue BPA, Thevissen K.

Peptides. 2018 Nov;109:33-38. doi: 10.1016/j.peptides.2018.08.013. Epub 2018 Aug 31.

PMID:
30176261
3.

Repurposing AM404 for the treatment of oral infections by Porphyromonas gingivalis.

Gerits E, Spincemaille P, De Cremer K, De Brucker K, Beullens S, Thevissen K, Cammue BPA, Vandamme K, Fauvart M, Verstraeten N, Michiels J.

Clin Exp Dent Res. 2017 Apr 7;3(2):69-76. doi: 10.1002/cre2.65. eCollection 2017 Apr.

4.

Alternating Current Electrophoretic Deposition for the Immobilization of Antimicrobial Agents on Titanium Implant Surfaces.

Braem A, De Brucker K, Delattin N, Killian MS, Roeffaers MB, Yoshioka T, Hayakawa S, Schmuki P, Cammue BP, Virtanen S, Thevissen K, Neirinck B.

ACS Appl Mater Interfaces. 2017 Mar 15;9(10):8533-8546. doi: 10.1021/acsami.6b16433. Epub 2017 Mar 6.

PMID:
28211996
5.

In vitro activity of the antiasthmatic drug zafirlukast against the oral pathogens Porphyromonas gingivalis and Streptococcus mutans.

Gerits E, Van der Massen I, Vandamme K, De Cremer K, De Brucker K, Thevissen K, Cammue BPA, Beullens S, Fauvart M, Verstraeten N, Michiels J, Roberts M.

FEMS Microbiol Lett. 2017 Jan 1;364(2). doi: 10.1093/femsle/fnx005.

PMID:
28087617
6.

Controlled release of chlorhexidine from a mesoporous silica-containing macroporous titanium dental implant prevents microbial biofilm formation.

De Cremer K, Braem A, Gerits E, De Brucker K, Vandamme K, Martens JA, Michiels J, Vleugels J, Cammue BP, Thevissen K.

Eur Cell Mater. 2017 Jan 11;33:13-27. doi: 10.22203/eCM.v033a02.

PMID:
28076651
7.

Repurposing Toremifene for Treatment of Oral Bacterial Infections.

Gerits E, Defraine V, Vandamme K, De Cremer K, De Brucker K, Thevissen K, Cammue BP, Beullens S, Fauvart M, Verstraeten N, Michiels J.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01846-16. doi: 10.1128/AAC.01846-16. Print 2017 Mar.

8.

Modulation of the Substitution Pattern of 5-Aryl-2-Aminoimidazoles Allows Fine-Tuning of Their Antibiofilm Activity Spectrum and Toxicity.

Peeters E, Hooyberghs G, Robijns S, Waldrant K, De Weerdt A, Delattin N, Liebens V, Kucharíková S, Tournu H, Verstraeten N, Dovgan B, Girandon L, Fröhlich M, De Brucker K, Van Dijck P, Michiels J, Cammue BP, Thevissen K, Vanderleyden J, Van der Eycken E, Steenackers HP.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6483-6497. doi: 10.1128/AAC.00035-16. Print 2016 Nov.

9.

Stimulation of superoxide production increases fungicidal action of miconazole against Candida albicans biofilms.

De Cremer K, De Brucker K, Staes I, Peeters A, Van den Driessche F, Coenye T, Cammue BP, Thevissen K.

Sci Rep. 2016 Jun 7;6:27463. doi: 10.1038/srep27463.

10.

Elucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosa.

Gerits E, Blommaert E, Lippell A, O'Neill AJ, Weytjens B, De Maeyer D, Fierro AC, Marchal K, Marchand A, Chaltin P, Spincemaille P, De Brucker K, Thevissen K, Cammue BP, Swings T, Liebens V, Fauvart M, Verstraeten N, Michiels J.

PLoS One. 2016 May 11;11(5):e0155139. doi: 10.1371/journal.pone.0155139. eCollection 2016.

11.

Antibacterial activity of a new broad-spectrum antibiotic covalently bound to titanium surfaces.

Gerits E, Kucharíková S, Van Dijck P, Erdtmann M, Krona A, Lövenklev M, Fröhlich M, Dovgan B, Impellizzeri F, Braem A, Vleugels J, Robijns SC, Steenackers HP, Vanderleyden J, De Brucker K, Thevissen K, Cammue BP, Fauvart M, Verstraeten N, Michiels J.

J Orthop Res. 2016 Dec;34(12):2191-2198. doi: 10.1002/jor.23238. Epub 2016 Apr 6.

12.

Covalent immobilization of antimicrobial agents on titanium prevents Staphylococcus aureus and Candida albicans colonization and biofilm formation.

Kucharíková S, Gerits E, De Brucker K, Braem A, Ceh K, Majdič G, Španič T, Pogorevc E, Verstraeten N, Tournu H, Delattin N, Impellizzeri F, Erdtmann M, Krona A, Lövenklev M, Knezevic M, Fröhlich M, Vleugels J, Fauvart M, de Silva WJ, Vandamme K, Garcia-Forgas J, Cammue BP, Michiels J, Van Dijck P, Thevissen K.

J Antimicrob Chemother. 2016 Apr;71(4):936-45. doi: 10.1093/jac/dkv437. Epub 2015 Dec 24.

PMID:
26702917
13.

Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.

De Brucker K, De Cremer K, Cammue BP, Thevissen K.

Methods Mol Biol. 2016;1333:67-72. doi: 10.1007/978-1-4939-2854-5_6.

PMID:
26468100
14.

Combinatorial drug approaches to tackle Candida albicans biofilms.

De Cremer K, Staes I, Delattin N, Cammue BP, Thevissen K, De Brucker K.

Expert Rev Anti Infect Ther. 2015 Aug;13(8):973-84. doi: 10.1586/14787210.2015.1056162. Epub 2015 Jun 12. Review.

PMID:
26070384
15.

Fungal β-1,3-glucan increases ofloxacin tolerance of Escherichia coli in a polymicrobial E. coli/Candida albicans biofilm.

De Brucker K, Tan Y, Vints K, De Cremer K, Braem A, Verstraeten N, Michiels J, Vleugels J, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2015;59(6):3052-8. doi: 10.1128/AAC.04650-14. Epub 2015 Mar 9.

16.

Novel anti-infective implant substrates: controlled release of antibiofilm compounds from mesoporous silica-containing macroporous titanium.

Braem A, De Cremer K, Delattin N, De Brucker K, Neirinck B, Vandamme K, Martens JA, Michiels J, Vleugels J, Cammue BP, Thevissen K.

Colloids Surf B Biointerfaces. 2015 Feb 1;126:481-8. doi: 10.1016/j.colsurfb.2014.12.054. Epub 2015 Jan 7.

PMID:
25601097
17.

2-(2-oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents.

Bardiot D, Thevissen K, De Brucker K, Peeters A, Cos P, Taborda CP, McNaughton M, Maes L, Chaltin P, Cammue BP, Marchand A.

J Med Chem. 2015 Feb 12;58(3):1502-12. doi: 10.1021/jm501814x. Epub 2015 Jan 28.

PMID:
25585716
18.

Identification and characterization of an anti-pseudomonal dichlorocarbazol derivative displaying anti-biofilm activity.

Liebens V, Gerits E, Knapen WJ, Swings T, Beullens S, Steenackers HP, Robijns S, Lippell A, O'Neill AJ, Veber M, Fröhlich M, Krona A, Lövenklev M, Corbau R, Marchand A, Chaltin P, De Brucker K, Thevissen K, Cammue BP, Fauvart M, Verstraeten N, Michiels J.

Bioorg Med Chem Lett. 2014 Dec 1;24(23):5404-8.

PMID:
25453797
19.

Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.

De Cremer K, Lanckacker E, Cools TL, Bax M, De Brucker K, Cos P, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2015 Jan;59(1):421-6. doi: 10.1128/AAC.04229-14. Epub 2014 Nov 3.

20.

Evaluation of the toxicity of 5-aryl-2-aminoimidazole-based biofilm inhibitors against eukaryotic cell lines, bone cells and the nematode Caenorhabditis elegans.

Steenackers H, Dubey A, Robijns S, Ermolat'ev D, Delattin N, Dovgan B, Girandon L, Fröhlich M, De Brucker K, Cammue BP, Thevissen K, Balzarini J, Van der Eycken EV, Vanderleyden J.

Molecules. 2014 Oct 16;19(10):16707-23. doi: 10.3390/molecules191016707.

21.

Oral administration of the broad-spectrum antibiofilm compound toremifene inhibits Candida albicans and Staphylococcus aureus biofilm formation in vivo.

De Cremer K, Delattin N, De Brucker K, Peeters A, Kucharíková S, Gerits E, Verstraeten N, Michiels J, Van Dijck P, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 Dec;58(12):7606-10. doi: 10.1128/AAC.03869-14. Epub 2014 Oct 6.

22.

Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation.

De Brucker K, Delattin N, Robijns S, Steenackers H, Verstraeten N, Landuyt B, Luyten W, Schoofs L, Dovgan B, Fröhlich M, Michiels J, Vanderleyden J, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 Sep;58(9):5395-404. doi: 10.1128/AAC.03045-14. Epub 2014 Jun 30.

23.

Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.

Delattin N, De Brucker K, Craik DJ, Cheneval O, De Coninck B, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 Aug;58(8):4974-7. doi: 10.1128/AAC.03336-14. Epub 2014 Jun 9.

24.

Plant-derived decapeptide OSIP108 interferes with Candida albicans biofilm formation without affecting cell viability.

Delattin N, De Brucker K, Craik DJ, Cheneval O, Fröhlich M, Veber M, Girandon L, Davis TR, Weeks AE, Kumamoto CA, Cos P, Coenye T, De Coninck B, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 May;58(5):2647-56. doi: 10.1128/AAC.01274-13. Epub 2014 Feb 24.

25.

Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.

Delattin N, De Brucker K, Vandamme K, Meert E, Marchand A, Chaltin P, Cammue BP, Thevissen K.

J Antimicrob Chemother. 2014 Apr;69(4):1035-44. doi: 10.1093/jac/dkt449. Epub 2013 Nov 27.

PMID:
24284780
26.

Potentiation of antibiofilm activity of amphotericin B by superoxide dismutase inhibition.

De Brucker K, Bink A, Meert E, Cammue BP, Thevissen K.

Oxid Med Cell Longev. 2013;2013:704654. doi: 10.1155/2013/704654. Epub 2013 Sep 1.

27.

Identification of fungicidal 2,6-disubstituted quinolines with activity against Candida biofilms.

Delattin N, Bardiot D, Marchand A, Chaltin P, De Brucker K, Cammue BP, Thevissen K.

Molecules. 2012 Oct 18;17(10):12243-51. doi: 10.3390/molecules171012243.

28.

Apoptosis-inducing antifungal peptides and proteins.

De Brucker K, Cammue BP, Thevissen K.

Biochem Soc Trans. 2011 Oct;39(5):1527-32. doi: 10.1042/BST0391527. Review.

PMID:
21936846
29.

Novel fungicidal benzylsulfanyl-phenylguanidines.

Thevissen K, Pellens K, De Brucker K, François IE, Chow KK, Meert EM, Meert W, Van Minnebruggen G, Borgers M, Vroome V, Levin J, De Vos D, Maes L, Cos P, Cammue BP.

Bioorg Med Chem Lett. 2011 Jun 15;21(12):3686-92. doi: 10.1016/j.bmcl.2011.04.075. Epub 2011 Apr 24.

PMID:
21576022
30.

Miconazole induces changes in actin cytoskeleton prior to reactive oxygen species induction in yeast.

Thevissen K, Ayscough KR, Aerts AM, Du W, De Brucker K, Meert EM, Ausma J, Borgers M, Cammue BP, François IE.

J Biol Chem. 2007 Jul 27;282(30):21592-7. Epub 2007 Jun 6.

Supplemental Content

Loading ...
Support Center